Latest Valvular heart disease Stories
Minneapolis Heart Institute Foundation is the first research center in the USA to report implant of a TMVR Device ROSEVILLE, Minn., April 13, 2015 /PRNewswire/ -- Tendyne Holdings,
FAVORABLE LATE-BREAKING CLINICAL TRIAL DATA FROM INITIAL COMMERCIAL USE PRESENTED ON TRANSCATHETER MITRAL VALVE REPAIR SYSTEM AT ACC 2015 SAN DIEGO, March 15, 2015 /PRNewswire/ -- About three
SAN DIEGO, March 15, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that
$15.2 Million Infusion from International Investors Rounds Out Financing; Funds Will Support Landmark Trial, Expand Commercial Operations KIRKLAND, Wash., March 11, 2015 /PRNewswire/
The new valve clinic in Youngstown, Ohio, provides a multidisciplinary team approach for diagnosing and treating patients with valvular heart disease. YOUNGSTOWN,
LUXEMBOURG, December 29, 2014 /PRNewswire/ -- Boulle Medtech Ltd, a Jean Boulle Group company focusing on medical technology and a founding investor of Tendyne Holdings,
Procedure is a result of looking at a medical problem through the eyes of an engineer. SALT LAKE CITY, Dec.
ROSEVILLE, Minn., Dec. 15, 2014 /PRNewswire/ -- Tendyne Holdings, Inc.
LUXEMBOURG, December 10, 2014 /PRNewswire/ -- Boulle Medtech Ltd., a Jean Boulle Group private company focusing on medical technology, and founding investor of Tendyne
ROSEVILLE, Minn., Dec. 2, 2014 /PRNewswire/ -- Tendyne Holdings, Inc.